Literature DB >> 1751621

Maladaptive anticipatory saccades in schizophrenia.

D W Hommer1, T Clem, R Litman, D Pickar.   

Abstract

We compared the saccades made by 8 neuroleptic-treated and 7 drug-free schizophrenic inpatients with those made by 11 normal controls during two eye movement tasks. The first task was designed to elicit visually guided but not internally guided saccades. The second task was designed so that optimal performance required saccades be guided on the basis of an internal representation of target behavior. During the first task, schizophrenics made visually guided saccades that were as accurate as those made by control, but both drug-free and neuroleptic-treated schizophrenics made intrusive saccades at a significantly higher rate than control subjects. Most of these maladaptive saccades appeared to be premature attempts to anticipate target jump. During the second eye movement task, which for optimal performance required use of an internal representation to guide eye movements, most patients learned to anticipate target jump as well as controls. However, neuroleptic-treated patients made significantly smaller adaptive anticipatory saccades than either drug-free schizophrenic patients or normal subjects. These finding are discussed as they relate to the prefrontal cortex-basal ganglia circuits involved in the regulation of behavior by representational knowledge and the idea that the abnormal anticipatory saccades we observed represent a failure in the sensorimotor gating of information derived from internal representations.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1751621     DOI: 10.1016/0006-3223(91)90234-d

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  12 in total

1.  Predictive saccades are impaired in biological nonpsychotic siblings of schizophrenia patients.

Authors:  Isabelle Amado; Steffen Landgraf; Marie-Chantal Bourdel; Sabinien Leonardi; Marie-Odile Krebs
Journal:  J Psychiatry Neurosci       Date:  2008-01       Impact factor: 6.186

2.  Impact of antipsychotic treatment on attention and motor learning systems in first-episode schizophrenia.

Authors:  Sarah K Keedy; James L Reilly; Jeffrey R Bishop; Peter J Weiden; John A Sweeney
Journal:  Schizophr Bull       Date:  2014-06-03       Impact factor: 9.306

3.  Saccadic eye movements in normal children from 8 to 15 years of age: a developmental study of visuospatial attention.

Authors:  R G Ross; A D Radant; D A Young; D W Hommer
Journal:  J Autism Dev Disord       Date:  1994-08

4.  Oculomotor inhibitory control in express saccade makers.

Authors:  Felicity D A Wolohan; Paul C Knox
Journal:  Exp Brain Res       Date:  2014-09-03       Impact factor: 1.972

Review 5.  The tell-tale tasks: a review of saccadic research in psychiatric patient populations.

Authors:  Diane C Gooding; Michele A Basso
Journal:  Brain Cogn       Date:  2008-10-23       Impact factor: 2.310

6.  Effects of risperidone on procedural learning in antipsychotic-naive first-episode schizophrenia.

Authors:  Margret S H Harris; Courtney L Wiseman; James L Reilly; Matcheri S Keshavan; John A Sweeney
Journal:  Neuropsychopharmacology       Date:  2008-06-04       Impact factor: 7.853

7.  Eye movement deficits in schizophrenia: investigation of a genetically homogenous Icelandic sample.

Authors:  H Magnus Haraldsson; Ulrich Ettinger; Brynja B Magnusdottir; Thordur Sigmundsson; Engilbert Sigurdsson; Hannes Petursson
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-04-24       Impact factor: 5.270

8.  Predictive eye and hand movements are differentially affected by schizophrenia.

Authors:  Uta Sailer; Thomas Eggert; Martin Strassnig; Michael Riedel; Andreas Straube
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-10       Impact factor: 5.270

9.  Beyond reliability: biomarkers and validity in psychiatry.

Authors:  Ronald Pies
Journal:  Psychiatry (Edgmont)       Date:  2008-01

Review 10.  Markers of vulnerability in schizophrenia.

Authors:  Maria Ladea; Dan Prelipceanu
Journal:  J Med Life       Date:  2009 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.